Randomized controlled trial to evaluate the effects of ethyl-2-cyanoacrylate on pain intensity and quality of life in head and neck cancer patients suffering from cetuximab-induced rhagades during radioimmunotherapy: the support trial

Peer Review reports

Original Submission
26 Sep 2012	Submitted	Original manuscript
5 Oct 2012	Author responded	Author comments - Karin Potthoff
Resubmission - Version 2
5 Oct 2012	Submitted	Manuscript version 2
9 Oct 2012	Author responded	Author comments - Karin Potthoff
Resubmission - Version 3
9 Oct 2012	Submitted	Manuscript version 3
21 Apr 2013	Reviewed	Reviewer Report - MARIO LACOUTURE
27 Apr 2013	Reviewed	Reviewer Report - Diana Steinmann
19 Oct 2013	Reviewed	Reviewer Report - Stefano Maria Magrini
11 Nov 2013	Reviewed	Reviewer Report - Siegfried Segaert
Resubmission - Version 4
	Submitted	Manuscript version 4
11 Mar 2014	Author responded	Author comments - Karin Potthoff
Resubmission - Version 5
11 Mar 2014	Submitted	Manuscript version 5
Publishing
19 Mar 2014	Editorially accepted
17 Apr 2014	Article published	10.1186/1471-2407-14-270

Back to article page